Treatment
This Treatment Block or turn off signals that tell cancer cells to grow and divide, Prevent the cells from living longer than normal, Destroy cancer cells.
What is a target therapy
EGFR
EGFR inhibitors used in NSCLC with EGFR gene mutations
Monitoring therapeutic and adverse effects.
The nurse must be familiar with each agent given and its potential effects, and also, the nurse must be aware of the impact of these side effects on the patient’s quality of life.
is approved to treat:
Kidney cancer
Liver cancer
Cabozantinib (Cometriq, Cabometyx
Which website encourages new explooratory and developemental research projects by providing support for early stages of cancer
NIH WEBSITE
This target therapy is approved by FDA to treat kidney cancer
Angiogenesis inhibiters
What are Multikinase inhibitors?
Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases
Promoting home and community-based care.
The nurse teaches the patient and family how to administer BRMs through subcutaneous injections, provides instructions about side effects and helps the patient and family identify
This kind of approach is called a "tumor-agnostic treatment."
There are also 2 checkpoint inhibitors that are used to treat tumors anywhere in the body if they have specific genetic changes.
This program offers up to years of funding usually not exceeding
$275,000 in grants
This tumor starving anti-angiogenetic therapy is approved to treat metastatic colorectal cancer mCRC.
What is Avastin
How do angiogenesis inhibitors treat cancer?
Angiogenesis is how the body forms new blood vessels. This is a normal part of growth and healing.
the strategies to manage many of the common side effects of BRM therapy.
provides instructions about side effects and helps the patient and family identify
is approved to treat:
Breast cancer
Everolimus (Afinitor)
NIH is the best practice for?
screening schedule
Drugs that target cells with EGFR gene changes
Epidermal growth factor receptor (EGFR)
tumor needs nutrients and oxygen from your blood to
Grow
the side effects of monoclonal antibodies used for targeted therapy are not like those used for immunotherapy.
The side effects of immune checkpoint inhibitors may include side effects similar to an allergic reaction
May be used to treat advanced kidney cancer as well as other specific types of cancer.
Multikinase inhibitors
Protecting caregivers
Nurses must be familiar with their institutional policies regarding personal protective equipment, handling and disposal of chemotherapeutic agents and supplies, and management of accidental spills or exposures.
immune checkpoint inhibitors include:
Atezolizumab (Tecentriq)
Avelumab (Bavencio)
Dostarlizumab (Jemperli)
Durvalumab (Imfinzi
What are monoclonal antibodies and immune checkpoint inhibitors?
Monoclonal antibodies are made in a laboratory to boost the body's natural antibodies or act as antibodies themselves.
Checkpoint inhibitors prevent cancer cells from blocking the
immune system. Common checkpoints that these inhibitors affect are the PD-1/PD-L1 and CTLA-4 pathways.
EGFR inhibitors used in NSCLC with EGFR gene mutations
Erlotinib (Tarceva)
Afatinib (Gilotrif)
Gefitinib (Iressa)
Osimertinib (Tagrisso)
Dacomitinib (Vizimpro)
Nurses play an important role in assessing and managing many of the problems experienced by patients undergoing chemotherapy
Modifying risks for infection and bleeding. Suppression of the bone marrow and immune system is expected and frequently serves as a guide in determining appropriate chemotherapy dosage but increases the risk of anemia, infection, and bleeding disorders.